Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Draper Dragon is a private cross-border venture capital firm founded in 2006 that connects Silicon Valley and Asia. The firm is part of the Draper Venture Network and invests primarily in early-stage technology companies, with its current public positioning emphasizing blockchain, Web3, and emerging technologies. Historical descriptions from third-party sources indicate the firm has also invested across broader technology and healthcare categories, but it is not itself a drug developer, healthcare operator, or life sciences products company. Draper Dragon appears to operate as an active investment platform rather than a biotech or pharma company, with offices across North America and Asia and a portfolio spanning software, crypto, and selected healthcare-related investments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Draper Dragon.